Wendall Wierenga's Net Worth
$10.8 Million
Who is Wendall Wierenga?
Wendall Wierenga has an estimated net worth of $10.8 Million. This is based on reported shares across multiple companies, which include Anacor Pharmaceuticals, Inc., NEUROCRINE BIOSCIENCES INC, Crinetics Pharmaceuticals, Inc., CYTOKINETICS INC, CONCERT PHARMACEUTICALS, INC., APRICUS BIOSCIENCES, INC., XENOPORT INC, SANTARUS INC, ONYX PHARMACEUTICALS INC, and Ocera Therapeutics, Inc..
SEC CIK
Wendall Wierenga's CIK is 0001235945
Past Insider Trading and Trends
2015 was Wendall Wierenga's most active year for acquiring shares with 12 total transactions. Wendall Wierenga's most active month to acquire stocks was the month of April. 2007 was Wendall Wierenga's most active year for disposing of shares, totalling 24 transactions. Wendall Wierenga's most active month to dispose stocks was the month of July. 2003 saw Wendall Wierenga paying a total of $5,897,955.64 for 144,523 shares, this is the most they've acquired in one year. In 2014 Wendall Wierenga cashed out on 378,838 shares for a total of $9,139,107.70, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Anacor Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -794.00 |
$99.25 | -$78,804.50 |
0
|
Jun 24
| |||
Form 4
|
∞
| 794 |
—
|
—
| 794 |
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEUROCRINE BIOSCIENCES INC (NBIX) Snapshot price: $135.96
EVP, Research & Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
| +67.43% | 2.02K |
$49.43 | $99,996.89 | 5.02K |
Oct 10
| |||
Form 4
|
∞
| 3K |
$53.58 | $160,740.00 | 3K |
Sep 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $37.69
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.21% | 3.4K |
—
|
—
| 109.25K |
Jun 7
| |||
Form 4
| +6.01% | 6K |
—
|
—
| 105.85K |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
| +33.99% | 25.33K |
$0.73 | $18,490.17 | 99.85K |
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CYTOKINETICS INC (CYTK) Snapshot price: $77.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.47% | 114 |
—
|
—
| 24.44K |
Jul 1
| |||
Form 4
| +29.90% | 5.6K |
—
|
—
| 24.33K |
May 15
| |||
Form 4
| +0.40% | 74 |
$84.12 | $6,224.88 | 18.73K |
Jan 2
| |||
Form 4
|
—
|
0
|
$39.02 | -$691,600.00 | 18.65K |
Scheduled
|
Dec 27
| ||
Form 4
| +2.46% | 448 |
$27.88 | $12,490.24 | 18.65K |
Oct 2
| |||
Form 4
|
—
|
0
|
$19.37 | -$152,306.00 | 18.2K |
Aug 21
| |||
Form 4
| +2.10% | 374 |
$33.36 | $12,476.64 | 18.2K |
Jul 3
| |||
Form 4
| +38.97% | 5K |
—
|
—
| 17.83K |
May 10
| |||
Form 4
| +2.38% | 298 |
$37.71 | $11,237.58 | 12.83K |
Apr 3
| |||
Form 4
|
—
|
0
|
$25.86 | -$267,960.00 | 12.53K |
Scheduled
|
Feb 6
| ||
Form 4
| +2.06% | 253 |
$44.35 | $11,220.55 | 12.53K |
Jan 3
| |||
Form 4
| +0.90% | 110 |
$51.11 | $5,622.10 | 12.28K |
Oct 3
| |||
Form 4
|
—
|
0
|
$29.79 | -$191,677.66 | 12.17K |
Scheduled
|
Sep 1
| ||
Form 4
| +1.14% | 137 |
$41.00 | $5,617.00 | 12.17K |
Jul 1
| |||
Form 4
| +71.09% | 5K |
—
|
—
| 12.03K |
May 10
| |||
Form 4
| +2.12% | 146 |
$38.38 | $5,603.48 | 7.03K |
Apr 1
| |||
Form 4
| +1.80% | 122 |
$46.00 | $5,612.00 | 6.89K |
Jan 3
| |||
Form 4
|
—
|
0
|
$24.92 | -$162,107.81 | 6.76K |
Scheduled
|
Dec 27
| ||
Form 4
| +4.74% | 306 |
$36.74 | $11,242.44 | 6.76K |
Oct 1
| |||
Form 4
| +0.98% | 63 |
$19.77 | $1,245.51 | 6.46K |
Jul 7
| |||
Form 4
| +8.04% | 476 |
$20.98 | $9,986.48 | 6.4K |
Jul 1
| |||
Form 4
| +543.48% | 5K |
—
|
—
| 5.92K |
May 12
| |||
Form 4
| +80.04% | 409 |
$24.44 | $9,995.96 | 920 |
Apr 1
| |||
Form 4
|
∞
| 511 |
$19.56 | $9,995.16 | 511 |
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
$13.12 | -$57,594.24 |
0
|
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CONCERT PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||